Based on the RELMADA THERAPEUT.DL-001 stock forecast from 0 analysts, the average analyst target price for RELMADA THERAPEUT.DL-001 is not available over the next 12 months. RELMADA THERAPEUT.DL-001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of RELMADA THERAPEUT.DL-001 is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, RELMADA THERAPEUT.DL-001’s stock price was EUR 0.34. RELMADA THERAPEUT.DL-001’s stock price has changed by +3.61% over the past week, -87.07% over the past month and -86.97% over the last year.
No recent analyst target price found for RELMADA THERAPEUT.DL-001
No recent average analyst rating found for RELMADA THERAPEUT.DL-001
Company Overview RELMADA THERAPEUT.DL-001
N/A
N/A
N/A
N/A
EUR
Germany
Adjusted Closing Price for RELMADA THERAPEUT.DL-001 (4E2:F)
Loading...
Unadjusted Closing Price for RELMADA THERAPEUT.DL-001 (4E2:F)
Loading...
Share Trading Volume for RELMADA THERAPEUT.DL-001 Shares
Loading...
Compare Performance of RELMADA THERAPEUT.DL-001 Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for 4E2:F
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To RELMADA THERAPEUT.DL-001 (Sector: Others )
Frequently Asked Questions About RELMADA THERAPEUT.DL-001 (4E2:F) Stock
Stock Target Advisor's fundamental analysis for RELMADA THERAPEUT.DL-001's stock is Very Bearish.
Unfortunately we do not have enough data on 4E2:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4E2:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4E2:F's stock to indicate if its overvalued.
The last closing price of 4E2:F's stock was EUR 0.34.
Unfortunately we do not currently have any market capitalization data for 4E2:F's stock.
Unfortunately we do not have enough analyst data on 4E2:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains RELMADA THERAPEUT.DL-001's stock.
Sorry, we do not have any data on the number of employees for RELMADA THERAPEUT.DL-001.
Sorry we do not have any infomation available on RELMADA THERAPEUT.DL-001's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Frequently Asked Questions About RELMADA THERAPEUT.DL-001 (4E2:F) Stock
Stock Target Advisor's fundamental analysis for RELMADA THERAPEUT.DL-001's stock is Very Bearish.
Unfortunately we do not have enough data on 4E2:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4E2:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4E2:F's stock to indicate if its overvalued.
The last closing price of 4E2:F's stock was EUR 0.34.
Unfortunately we do not currently have any market capitalization data for 4E2:F's stock.
Unfortunately we do not have enough analyst data on 4E2:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains RELMADA THERAPEUT.DL-001's stock.
Sorry, we do not have any data on the number of employees for RELMADA THERAPEUT.DL-001.
Sorry we do not have any infomation available on RELMADA THERAPEUT.DL-001's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4E2:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
